Home > Insider Trading > Filing (0000899243-18-027480)

Filing Details

Accession Number:: 0000899243-18-027480
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-25 18:27:41
Reporting Period:: 2018-10-23

Accepted Time:: 2018-10-25 18:27:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1664106	Logicbio Therapeutics Inc.	LOGC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1568077	Tomer Kariv	C/O Logicbio Therapeutics, Inc. 610 Main St., 3Rd Floor Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-23	674,431	$0.00	674,431	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	364,643	$0.00	1,039,074	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	328,339	$0.00	1,367,413	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	207,151	$10.00	1,574,564	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	112,000	$10.00	1,686,564	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-10-23	100,849	$10.00	1,787,413	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-10-23	1,288,116	$0.00	674,431	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-10-23	696,444	$0.00	364,643	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-10-23	627,105	$0.00	328,339	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
692,982	No	4	C	Indirect
328,339	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

Upon closing of the Issuer's initial public offering, each share of Series B Convertible Preferred Stock automatically converted into 0.5235794 shares of Common Stock without payment or further consideration. There was no expiration date for the Series B Convertible Preferred Stock.
Represents shares of the Issuer held by Pontifax (Israel) IV, L.P. ("Israel IV"). Pontifax IV GP L.P. ("Pontifax IV") is the general partner of Israel IV. Pontifax Management 4 G.P. (2015) Ltd. ("Management 4") is the general partner of Pontifax IV. The Reporting Person is a Managing Partner of Management 4. By virtue of this relationship, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares held by Israel IV. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise of such portion of these securities in which he has no pecuniary interest.
Represents shares of the Issuer held by Pontifax (China) IV, L.P. ("China IV"). Pontifax IV is the general partner of China IV. Management 4 is the general partner of Pontifax IV. By virtue of this relationship, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares held by China IV. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Exchange Act or otherwise of such portion of these securities in which he has no pecuniary interest.
Represents shares of the Issuer held by Pontifax (Cayman) IV, L.P. ("Cayman IV"). Pontifax IV is the general partner of Cayman IV. Management 4 is the general partner of Pontifax IV. By virtue of this relationship, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares held by Cayman IV. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Exchange Act or otherwise of such portion of these securities in which he has no pecuniary interest.